{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:18Z","timestamp":1786979898586,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T00:00:00Z","timestamp":1115856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00262-005-0696-z","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T04:44:37Z","timestamp":1115786677000},"page":"1106-1114","source":"Crossref","is-referenced-by-count":9,"title":["Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain"],"prefix":"10.1007","volume":"54","author":[{"given":"Guo","family":"Xiaoling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huifang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Qingqing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,12]]},"reference":[{"issue":"6","key":"696_CR1","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1073\/pnas.72.6.2357","volume":"72","author":"CA Janeway Jr","year":"1975","unstructured":"Janeway CA Jr, Sakato N, Eisen HN (1975) Recognition of immunoglobulin idiotypes by thymus-derived lymphocytes. Proc Natl Acad Sci USA 72(6):2357\u20132360","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"696_CR2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/eji.1830161110","volume":"16","author":"B Bogen","year":"1986","unstructured":"Bogen B, Malissen B, Haas W (1986) Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur J Immunol 16(11):1373\u20131378","journal-title":"Eur J Immunol"},{"key":"696_CR3","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.139.8.2825","volume":"139","author":"Campbell","year":"1987","unstructured":"Campbell MJ, Carroll W, Kon S, Thielemans K, Rothbard JB, Levy S, Levy R (1987) Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J Immunol 15 139(8):2825\u20132833","journal-title":"J Immunol 15"},{"key":"696_CR4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM198203043060906","volume":"306","author":"Miller","year":"1982","unstructured":"Miller RA, Maloney DG, Warnke R, Levy R (1982) Treatment of B-cell malignancies with monoclonal anti-idiotype antibody. N Engl J Med 4 306(9):517\u2013522","journal-title":"N Engl J Med 4"},{"issue":"3","key":"696_CR5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.145.3.1029","volume":"145","author":"MJ Campbell","year":"1990","unstructured":"Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R (1990) Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol 145(3):1029\u20131036","journal-title":"J Immunol"},{"issue":"6","key":"696_CR6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood.V80.6.1502.1502","volume":"80","author":"DG Maloney","year":"1992","unstructured":"Maloney DG, Brown S, Czerwinski DK, Liles TM, Hart SM, Miller RA, Levy R (1992) Monoclonal anti-idiotype antibody therapy of B-cell malignancies: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood 80(6):1502\u20131510","journal-title":"Blood"},{"issue":"10","key":"696_CR7","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.4049\/jimmunol.153.10.4775","volume":"153","author":"TT Chen","year":"1994","unstructured":"Chen TT, Tao MH, Levy R (1994) Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J Immunol 153(10):4775\u20134787","journal-title":"J Immunol"},{"issue":"4","key":"696_CR8","first-page":"400","volume":"87","author":"Y Barrios","year":"2002","unstructured":"Barrios Y, Cabrera R, Yanez R, Briz M, Plaza A, Fores R (2002) Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma. Haematologica 87(4):400\u2013407","journal-title":"Haematologica"},{"issue":"9","key":"696_CR9","first-page":"989","volume":"87","author":"PA Ruffini","year":"2002","unstructured":"Ruffini PA, Neelapu SS, Kwak LW, Biragyn A (2002) Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Haematologica 87(9):989\u20131001","journal-title":"Haematologica"},{"issue":"4","key":"696_CR10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/eji.1830270435","volume":"27","author":"YJ Wen","year":"1997","unstructured":"Wen YJ, Lim SH. (1997) T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin\u2019s lymphoma. Eur J Immunol 27(4):1043\u20131047","journal-title":"Eur J Immunol"},{"issue":"5","key":"696_CR11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<671::AID-IJC7>3.0.CO;2-E","volume":"80","author":"J Fagerberg","year":"1999","unstructured":"Fagerberg J, Yi Q, Gigliotti D, Harmenberg U, Ruden U, Persson B, Osterborg A, Mellstedt H (1999) T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma. Int J Cancer 80(5):671\u2013680","journal-title":"Int J Cancer"},{"issue":"3","key":"696_CR12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-3083.1999.00599.x","volume":"50","author":"YJ Wen","year":"1999","unstructured":"Wen YJ, Lim SH (1999) Different properties of T-cell epitopes within complementarity-determining regions 1 and 2 of idiotypic VH in B-lymphoma. Scand J Immunol 50(3):296\u2013301","journal-title":"Scand J Immunol"},{"issue":"1","key":"696_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2141.2000.02307.x","volume":"111","author":"MR Rezvany","year":"2000","unstructured":"Rezvany MR, Jeddi-Tehrani M, Rabbani H, Ruden U, Hammarstrom L, Osterborg A, Wigzell H, Mellstedt H (2000) Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia. Br J Haematol 111(1):230\u2013238","journal-title":"Br J Haematol"},{"issue":"12","key":"696_CR14","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2002-04-1250","volume":"101","author":"L Hansson","year":"2003","unstructured":"Hansson L, Rabbani H, Fagerberg J, Osterborg A, Mellstedt H (2003) T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma. Blood 101(12):4930\u20134936","journal-title":"Blood"},{"issue":"6","key":"696_CR15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/76243","volume":"6","author":"A Trojan","year":"2000","unstructured":"Trojan A, Schultze JL, Witzens M, Vonderheide RH, Ladetto M, Donovan JW, Gribben JG (2000) Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies. Nat Med 6(6):667\u2013672","journal-title":"Nat Med"},{"issue":"3","key":"696_CR16","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2004-01-0105","volume":"104","author":"Q Lou","year":"2004","unstructured":"Lou Q, Kelleher RJ Jr, Sette A, Loyall J, Southwood S, Bankert RB, Bernstein SH (2004) Germ line tumor-associated immunoglobulin IgHV region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells. Blood 104(3):752\u2013759","journal-title":"Blood"},{"issue":"4","key":"696_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000019115","volume":"16","author":"D Scaviner","year":"1999","unstructured":"Scaviner D, Barbie V, Ruiz M, Lefranc MP (1999) Protein displays of the human immunoglobulin heavy, kappa and lambda variable and joining regions. Exp Clin Immunogenet 16(4):234\u2013240","journal-title":"Exp Clin Immunogenet"},{"issue":"2","key":"696_CR18","first-page":"126","volume":"10","author":"NJ Lin","year":"2002","unstructured":"Lin NJ, Zhu P, Zhang YP, Shi YJ, Zhang X, Bu DF, Dong YJ (2002) The experimental study on the idiotypic nucleic Acid vaccine constructed from the genomic DNA to lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 10(2):126\u2013130","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"11","key":"696_CR19","first-page":"766","volume":"82","author":"N Lin","year":"2002","unstructured":"Lin N, Zhu P, Zhang X, Dong Y, Ren Y, Wang Y, Li W (2002) Specific humoral immune response against B-cell lymphoma elicited by mixed immunoglobulin fragments. Zhonghua Yi Xue Za Zhi 82(11):766\u2013770","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"696_CR20","first-page":"48","volume":"84","author":"H Liu","year":"2004","unstructured":"Liu H, Zhu P, Lin NJ, Zhang Y, Bu DF, Wang YJ, Wang YQ, Yang Y (2004) Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine. Zhonghua Yi Xue Za Zhi 84(1):48\u201353","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"696_CR21","first-page":"68","volume":"23","author":"Y Zhang","year":"2002","unstructured":"Zhang Y, Zhu P, Shi Y, Liu J, Pu D, Cao X, Zhu Q, Wang Y, Ma M, Yu J (2002) Experimental study on TCRbeta idiotypic antigenic determinants DNA vaccine to induce anti-lymphoma antibodies. Zhonghua Xue Ye Xue Za Zhi 23(2):68\u201372","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"696_CR22","first-page":"8","volume":"25","author":"Y Liu","year":"2004","unstructured":"Liu Y, Zhu P, Hu YM (2004) Characteristics of immunoglobulin heavy chain variable region genes in childhood B-cell acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi 25(1):8\u201312","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"696_CR23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1074-7613(00)80066-7","volume":"10","author":"RH Vonderheide","year":"1999","unstructured":"Vonderheide RH, Hahn WC, Schultze JL, Nadler LM (1999) The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10:673\u2013679","journal-title":"Immunity"},{"issue":"16","key":"696_CR24","first-page":"4499","volume":"60","author":"D Valmori","year":"2000","unstructured":"Valmori D, Dutoit V, Lienard D, Rimoldi D, Pittet MJ, Champagne P, Ellefsen K, Sahin U, Speiser D, Lejeune F, Cerottini JC, Romero P (2000) Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res 60(16):4499\u20134506","journal-title":"Cancer Res"},{"issue":"10","key":"696_CR25","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood.V98.10.2887","volume":"98","author":"RE Clark","year":"2001","unstructured":"Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, Macintyre AR, Seran C (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 98(10):2887\u20132893","journal-title":"Blood"},{"issue":"10","key":"696_CR26","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2003-05-1524","volume":"102","author":"MH Heemskerk","year":"2003","unstructured":"Heemskerk MH, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA (2003) Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 102(10):3530\u20133540","journal-title":"Blood"},{"issue":"4","key":"696_CR27","first-page":"405","volume":"11","author":"YH Yang","year":"2003","unstructured":"Yang YH, Li HF, Zhu P (2003) The T-lymphocyte clonal proliferation in a patient with chronic eosinophilic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 11(4):405\u2013408","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"3","key":"696_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01682036","volume":"70","author":"E Weidmann","year":"1995","unstructured":"Weidmann E, Brieger J, Jahn B, Hoelzer D, Bergmann L, Mitrou PS (1995) Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Ann Hematol 70(3):153\u2013158","journal-title":"Ann Hematol"},{"issue":"(10","key":"696_CR29","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood.V98.10.2999","volume":"98","author":"S Harig","year":"2001","unstructured":"Harig S, Witzens M, Krackhardt AM, Trojan A, Barrett P, Broderick R, Zauls AJ, Gribben JG (2001) Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues. Blood 98(10):2999\u20133005","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0696-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0696-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0696-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T02:03:16Z","timestamp":1683079396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0696-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,12]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0696-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,12]]}}}